(Q33353559)

26 July 2017

title

Fotemustine plus dacarbazine in advanced stage III malignant melanoma (English)

1 reference

26 July 2017

1 reference

M. Binder

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1389516

21 September 2022

A. Winkler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1389516

21 September 2022

R. Dorffner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1389516

21 September 2022

E. Glebowski

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1389516

21 September 2022

K. Wolff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1389516

21 September 2022

H. Pehamberger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1389516

21 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1389516

21 September 2022

publication date

1 January 1992

1 reference

European Journal of Cancer

26 July 2017

published in

1 reference

26 July 2017

volume

28A

1 reference

26 July 2017

issue

11

1 reference

26 July 2017

page(s)

1814-1816

1 reference

10.1016/0959-8049(92)90010-Y

26 July 2017

Identifiers

DOI

1 reference

26 July 2017

1 reference